Overview

Pharmaceutical giants have doubled their investments in drug development in the past decade only to see new drug approvals remain constant. This book investigates and highlights a set of proactive strategies aimed at generating sustainable competitive advantage based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. Our findings are illustrated by cases from Europe, the US, and Asia.   

Full Product Details

Author:   Oliver Gassmann ,  Gerrit Reepmeyer ,  Maximilian von Zedtwitz
Publisher:   Springer-Verlag Berlin and Heidelberg GmbH & Co. KG
Imprint:   Springer-Verlag Berlin and Heidelberg GmbH & Co. K
Edition:   2nd ed. 2008
Dimensions:   Width: 15.50cm , Height: 1.20cm , Length: 23.50cm
Weight:   0.477kg
ISBN:  

9783540776352

ISBN 10:   3540776354
Pages:   186
Publication Date:   03 March 2008
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   In Print  
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

Reviews

From the reviews: <p> This book examines the international pharmaceutical industry with special emphasis on the current and emerging research methodologies a ] . What distinguishes this book from others on the same subject is its emphasis on empirical findings (53 figures, 20 tables) and an exceptionally good, if short, discussion of various research technologies a ] . The six-page glossary of industry terms, when used with its decent index, is a particular joy. a ] recommend this offering to prospective managers and researchers in this industry a ] . (Robert R. Rothberg, Journal of Product Innovation Management, Vol. 22, 2005)

From the reviews: This book examines the international pharmaceutical industry with special emphasis on the current and emerging research methodologies ! . What distinguishes this book from others on the same subject is its emphasis on empirical findings (53 figures, 20 tables) and an exceptionally good, if short, discussion of various research technologies ! . The six-page glossary of industry terms, when used with its decent index, is a particular joy. ! recommend this offering to prospective managers and researchers in this industry ! . (Robert R. Rothberg, Journal of Product Innovation Management, Vol. 22, 2005) From the reviews of the second edition: Leading Pharmaceutical Innovation, Gassmann and colleagues describe the current status of the pharmaceutical industry ! . This book comprises seven chapters, where each could be seen as a review of the addressed topic. This helps with understanding the complexity of the challenges the pharmaceutical industry is facing, in comparison to the automotive industry or with respect to marketing problems ! . book provides most valuable insight into the pharmaceutical industry from an 'outsiders' perspective. (Sandrine Shepard and Thomas Wilckens, R&D Management, Vol. 40 (5), November, 2010)

"From the reviews: ""This book examines the international pharmaceutical industry with special emphasis on the current and emerging research methodologies … . What distinguishes this book from others on the same subject is its emphasis on empirical findings (53 figures, 20 tables) and an exceptionally good, if short, discussion of various research technologies … . The six-page glossary of industry terms, when used with its decent index, is a particular joy. … recommend this offering to prospective managers and researchers in this industry … ."" (Robert R. Rothberg, Journal of Product Innovation Management, Vol. 22, 2005) From the reviews of the second edition: “Leading Pharmaceutical Innovation, Gassmann and colleagues describe the current status of the pharmaceutical industry … . This book comprises seven chapters, where each could be seen as a review of the addressed topic. This helps with understanding the complexity of the challenges the pharmaceutical industry is facing, in comparison to the automotive industry or with respect to marketing problems … . book provides most valuable insight into the pharmaceutical industry from an ‘outsiders’ perspective.” (Sandrine Shepard and Thomas Wilckens, R&D Management, Vol. 40 (5), November, 2010)"

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions